LL-37 5mg (CAP-18)

Description

LL-37 is a cationic α-helical research peptide derived from the C-terminal region of human cathelicidin (hCAP18). It exhibits broad-spectrum antimicrobial and immunomodulatory activity in preclinical studies, acting via membrane disruption and modulation of TLR/NF-κB pathways. LL-37 is widely used in microbiology and immunology research investigating host defense peptides and innate immune signaling.

For research use only. Not for human consumption.

References:
Dürr UH et al., Biochim Biophys Acta, 2006 1758(9):1408–1425
Zanetti M et al., J Leukoc Biol, 2004 75(1):39–48
Vandamme D et al., Cell Mol Life Sci, 2012 69(2):210–227